LGND Ligand Pharmaceuticals Incorporated
Stock · NasdaqGM · United States · Healthcare · US53220K5048
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Ligand Pharmaceuticals Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 06 Nov 2026 16:22. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Sep 2022 | 57.43 | 60.65 | 47.79 | 53.72 | -6.80% | 5,153,644 | |
| Aug 2022 | 57.08 | 68.00 | 55.06 | 57.64 | +0.39% | 3,820,429 | |
| Jul 2022 | 55.23 | 61.52 | 54.44 | 57.41 | +3.15% | 3,399,804 | |
| Jun 2022 | 55.76 | 56.67 | 45.27 | 55.66 | +0.35% | 5,348,571 | |
| May 2022 | 58.11 | 60.51 | 48.53 | 55.46 | -4.25% | 5,437,377 | |
| Apr 2022 | 71.05 | 73.85 | 56.66 | 57.93 | -17.45% | 4,767,003 | |
| Mar 2022 | 62.67 | 75.90 | 60.14 | 70.17 | +11.13% | 5,769,037 | |
| Feb 2022 | 77.67 | 80.17 | 55.21 | 63.14 | -18.78% | 5,364,920 | |
| Jan 2022 | 96.39 | 97.49 | 69.25 | 77.75 | -19.31% | 5,250,145 | |
| Dec 2021 | 102.76 | 102.83 | 84.42 | 96.36 | -4.61% | 4,564,221 | |
| Nov 2021 | 95.65 | 106.04 | 93.57 | 101.01 | — | 3,515,860 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 299.00 USD
- Market cap
- 6.0B
- Last dividend
- 9.3575 USD · 02 Jul 2010
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 03 Apr 2007 | 9.3575 USD |
Follow LGND and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.